Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Deposit

v3.19.1
Note 6 - Deposit
3 Months Ended
Mar. 31, 2019
Notes to Financial Statements  
Other Assets Disclosure [Text Block]
6.
Deposit
 
Deposit consisted of the following (in thousands):
   
March 31, 2019
   
December 31, 201
8
 
Advances to vendor
  $
271
    $
271
 
Total deposit
  $
271
    $
271
 
 
We have advanced funds to a vendor engaged to support the performance of the REMEDY Phase
2
clinical trial. The funds advanced will be held, interest free, by this vendor until the completion of the trial and applied to final trial invoices or refunded. This deposit is classified as non-current as the trial is
not
expected to be completed during
2019.